(Q31093609)

28 June 2017

1 reference

title

Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research (English)

1 reference

28 June 2017

0 references

0 references

1

1 reference

28 June 2017

Malgorzata Marjanska

2

1 reference

28 June 2017

Thomas M Wengenack

3

1 reference

28 June 2017

Denise A Reyes

4

1 reference

28 June 2017

Geoffrey L Curran

5

1 reference

28 June 2017

Joseph Lin

6

1 reference

28 June 2017

Gregory M Preboske

7

1 reference

28 June 2017

Joseph F Poduslo

8

1 reference

28 June 2017

Michael Garwood

9

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

28 June 2017

1 reference

28 June 2017

volume

13

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

38-48

1 reference

2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

The return of the frequency sweep: designing adiabatic pulses for contemporary NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

19F and 1H MRI detection of amyloid beta plaques in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Characterization of Radioiodinated Ligand Binding to Amyloid β Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Role of Increased Cerebral myo‐Inositol in the Dementia of Down Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858406295610

21 January 2018

Identifiers

DOI

10.1177/1073858406295610

1 reference

28 June 2017

1 reference